Quantum Biopharma reported cash from operations of -$1.79M and free cash flow of -$1.79M for the quarter ended Jun 2026, up 58.0% year over year. This cash flow statement covers 29 quarters of results from Mar 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||||||||||||||||
| Net Income | -13.21M | -5.79M | -6.35M | 5.91M | -4.42M | -7.13M | -6.15M | -9.94M | -5.72M | -0.86M | -1.70M | -2.09M | -3.35M | -9.47M | -8.74M | -9.77M | -8.45M | -13.75M | -3.09M | ||||||||||
| Depreciation and DepletionDep. & Depletion | 0.01M | 0.33M | 0.12M | 0.01M | 0.01M | 0.11M | |||||||||||||||||||||||
| Share-based CompensationStock Comp. | 3.02M | 0.25M | 0.34M | 0.08M | 0.36M | 0.59M | 0.51M | 3.21M | 0.40M | 0.13M | 0.10M | 0.06M | 0.11M | -0.02M | 0.29M | 0.85M | 1.80M | 0.89M | 0.01M | ||||||||||
| Cash from Discontinued OperationsCash from Discont. Ops | 0.24M | 0.31M | -2.61M | -0.50M | |||||||||||||||||||||||||
| Gains from Sales and DivestituresGains Divest | 0.02M | -0.07M | 0.07M | -0.18M | -0.00M | 0.00M | |||||||||||||||||||||||
| Gains from Investment SecuritiesGains Investment | 0.38M | 0.76M | 0.68M | 0.12M | |||||||||||||||||||||||||
| Asset Writedowns and ImpairmentWritedown | 0.09M | 0.48M | 3.84M | 0.24M | |||||||||||||||||||||||||
| Cash from OperationsCash from Ops. | 6.58M | 4.59M | -37.40M | 5.09M | 9.40M | 7.52M | -50.34M | -4.75M | -0.85M | -1.97M | -0.61M | -4.30M | -4.26M | -1.95M | -2.03M | -1.67M | -1.79M | ||||||||||||
| Depreciation, Depletion & Amortization | |||||||||||||||||||||||||||||
| Depreciation & Amortization (CF)Dep. & Amort. | 0.98M | 1.00M | 1.11M | 1.10M | 1.13M | 1.15M | 1.15M | 1.13M | 1.11M | 0.15M | 0.12M | 0.12M | 0.14M | 0.12M | 0.13M | 0.14M | 0.27M | 0.13M | 0.13M | ||||||||||
| Change in Working Capital | |||||||||||||||||||||||||||||
| Change in ReceivablesChange Receivables | 0.29M | -0.55M | 0.10M | 0.17M | -0.53M | 0.63M | -0.05M | -0.05M | 0.06M | 0.17M | -0.01M | 0.06M | 0.08M | -0.29M | 0.10M | 0.08M | 0.02M | 0.02M | 0.10M | ||||||||||
| Change in InventoryChange Inventory | -0.12M | 0.02M | 0.02M | 0.02M | 665.00 | -0.00M | |||||||||||||||||||||||
| Change in Account PayablesChange Payables | 2.08M | -0.97M | 0.68M | 0.44M | -0.24M | -1.62M | 0.72M | 0.61M | 0.31M | 0.55M | 0.58M | -1.05M | 1.03M | 4.29M | -0.18M | 0.15M | 1.21M | -3.26M | 4.43M | ||||||||||
| Other Working Capital ChangesOther WC Changes | -0.41M | -1.58M | -0.04M | 0.20M | -0.02M | 0.04M | 0.58M | -0.37M | 0.33M | 0.15M | 0.19M | -0.12M | 0.14M | 0.06M | -0.08M | -0.31M | 0.44M | -0.06M | 0.02M | ||||||||||
| Investing Activities | |||||||||||||||||||||||||||||
| Capital ExpendituresCapex | -0.01M | -0.01M | -0.10M | 0.23M | |||||||||||||||||||||||||
| Sales of Property, Plant and EquipmentPP&E (Sale) | 0.16M | -0.44M | 0.46M | ||||||||||||||||||||||||||
| Change in IntangiblesChange Intangibless | 0.05M | -1.05M | -0.25M | -1.00M | 1.00M | 0.27M | 0.09M | 2.15M | 0.07M | ||||||||||||||||||||
| Acquisitions | |||||||||||||||||||||||||||||
| Change in Acquisitions & DivestmentsChange Acquisitions | 0.01M | -0.01M | -0.74M | -0.02M | 0.76M | 5.45M | 1.18M | ||||||||||||||||||||||
| Cash from Investing ActivitiesCash from Investing | -1.00M | 0.72M | -0.22M | -0.11M | -0.61M | -0.27M | -0.02M | 0.74M | -2.22M | -1.35M | -1.36M | 0.76M | -2.89M | -1.36M | |||||||||||||||
| Financing Activities | |||||||||||||||||||||||||||||
| Cash from Financing ActivitiesCash from Financing | -0.06M | -0.02M | -0.01M | 1.49M | 0.28M | 0.26M | -4.09M | -3.00M | -0.03M | 0.57M | 1.84M | 9.21M | 3.13M | 1.29M | 1.68M | 7.00M | 2.46M | ||||||||||||
| Change in Capital Stock | |||||||||||||||||||||||||||||
| Net Equity Issued and RepurchasedNet Equity Issued | 1.47M | 0.23M | 0.22M | -1.93M | -2.96M | 2.96M | 0.30M | -0.30M | 10.67M | -10.67M | 0.05M | -0.00M | |||||||||||||||||
| Additional items | |||||||||||||||||||||||||||||
| Exchange Rate EffectFX Effect | -6.64M | 28.57M | 3.05M | ||||||||||||||||||||||||||
| Change in Cash | -6.64M | -3.88M | -4.06M | 6.69M | -3.05M | 7.87M | -29.79M | -7.76M | -0.88M | -1.43M | 1.98M | 2.69M | -2.48M | -2.02M | 0.41M | 2.44M | -0.69M | ||||||||||||
| Beginning Cash Balance | 35.26M | 16.98M | 2.76M | 6.00M | 1.91M | ||||||||||||||||||||||||
| Free Cash FlowFCF | 6.58M | 4.59M | -37.40M | 5.11M | 9.40M | 7.61M | -50.57M | -4.75M | -0.85M | -1.97M | -0.61M | -4.30M | -4.26M | -1.95M | -2.03M | -1.67M | -1.79M | ||||||||||||
| Net Cash FlowNCF | 5.53M | 5.29M | -37.64M | 6.47M | 9.67M | 7.77M | -55.04M | -7.76M | -0.27M | -0.88M | -1.43M | 1.98M | 2.69M | -2.48M | -2.02M | 0.41M | 2.44M | -0.69M |
Pull Quantum Biopharma's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/statements?ticker=QNTM&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/statements"
params = {"ticker": "QNTM", "statement": "CF", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/statements?ticker=QNTM&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();